Bariatric surgery, the most effective treatment for obesity and type 2 diabetes, is consistently 18 associated with increased levels of the incretin hormone GLP-1 and changes in overall levels of 19 circulating bile acids. The levels of individual bile acids in the GI tract following surgery, however, 20 have remained largely unstudied. Using UPLC-MS-based quantification, we observed an 21 increase in an endogenous bile acid, cholic acid-7-sulfate (CA7S), in the GI tract of both mice and 22 humans after sleeve gastrectomy. We show that CA7S is a TGR5 agonist that induces GLP-1 23 secretion in vitro and in vivo and that CA7S administration increases glucose tolerance in insulin-24 resistant mice in a GLP-1 receptor-dependent manner. CA7S remains gut-restricted, minimizing 25 off-target effects previously observed for TGR5 agonists absorbed into circulation. By studying 26 changes in individual metabolites following surgery, this study has revealed a naturally occurring 27 TGR5 agonist that exerts systemic glucoregulatory effects while remaining confined to the gut.
obstacle could be overcome, performing SG on CA7S-depleted mice would help to reveal the 217 contribution of this molecule to the metabolic effects of the surgery.
219
More broadly, prior to this work, there were no known individual metabolites whose levels were 220 altered by bariatric surgery that could increase blood glucose clearance. Through the climate-controlled environment with 12 hour light and dark cycles and reared on a high fat diet 227 (HFD, 60% Kcal fat; RD12492; Research Diets, NJ). They were allowed to acclimate for at least 228 1 week prior to undergoing any procedures. All animals were cared for according to guidelines 229 set forth by the American Association for Laboratory Animal Science. All procedures were 230 approved by the Institutional Animal Care and Use Committee.
232
Sleeve gastrectomy (SG) and sham procedures. 11-week-old DIO mice were purchased and 233 housed as described above. Mice were weight-matched into two groups and either underwent SG 234 or Sham operation. SG was performed through a 1.5 cm midline laparotomy under isoflurane 235 anesthesia. The stomach was gently dissected free from its surrounding attachments, the vessels 236 between the spleen and stomach (short gastric vessels) were divided, and a tubular stomach was 237 created by removing 80% of the glandular and 100% of the non-glandular stomach with a linear-238 cutting surgical stapler. Sham operation consisted of a similar laparotomy, stomach dissection, 239 ligation of short gastric vessels, and manipulation of the stomach along the staple line equivalent.
240
Mice were then individually housed thereafter to allow for monitoring of food intake, weight, and 241 behavior. SG and Sham mice were maintained on Recovery Gel Diet (Clear H2O, Westbrook, 242 ME) from 1 day prior through 6 days after surgery and then were restarted on HFD on the morning 243 of post-operative day (POD) 7. Mice were sacrificed 5-7 weeks post-surgery.
245
Functional glucose testing. After a 4 hour fast (8 am to noon), intraperitoneal glucose tolerance 246 testing (IPGTT) and insulin tolerance testing (ITT) were performed at post-operative week 4 and 247 5, respectively. During IPGTT, mice received 2 mg/g of intraperitoneal D-Glucose (Sigma-Aldrich, measured for each set prior to medication administration.
254
Body weight and food intake measurements. Mice were individually housed and weighed daily 255 for the first post-operative week and then twice weekly until sacrifice. Food intake was measured 256 twice weekly and daily food intake was calculated by averaging the grams eaten per day over the 257 preceding days. Note that food intake measurements were started on POD 10 as animals were 258 transitioned from Gel Diet to high fat diet on the morning of POD 7.
260
Bile acid analysis. Bile acid analyses were performed using a previously reported method 23 .
261
Reagents. Stock solutions of all bile acids were prepared by dissolving the compounds in 262 molecular biology grade DMSO (VWR International, Radnor, PA). These solutions were used to 263 establish standard curves. CA7S was purchased from (Caymen Chemicals, Ann Arbor, MI. Cat.
264
No. 9002532). Glyocholic acid (GCA) (Sigma) was used as the internal standard for 265 measurements in mouse tissues. HPLC grade solvents were used for preparing and running 37 after incubation at 37 ˚C in buffer at the indicated physiological pHs. All data are presented as 717 mean ± SEM.
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